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Reoptimization of the Organocatalyzed Double Aldol Domino
Process to a Key Enal Intermediate and Its Application to the
Total Synthesis of D12-Prostaglandin J3
Andrejs Pelsˇs,[a] Narasimhulu Gandhamsetty,[a] James R. Smith,[a] Damien Mailhol,[a]
Mattia Silvi,[a] Andrew J. A. Watson,[a] Isabel Perez-Powell,[a] S8bastien Pr8vost,[a]
Nina Schetzenmeister,[a] Peter R. Moore,[b] and Varinder K. Aggarwal*[a]
Abstract: Re-investigation of the l-proline catalyzed
double aldol cascade dimerization of succinaldehyde for
the synthesis of a key bicyclic enal intermediate, pertinent
in the field of stereoselective prostaglandin synthesis, is
reported. The yield of this process has been more than
doubled, from 14% to a 29% isolated yield on a multi-
gram scale (32% NMR yield), through conducting a de-
tailed study of the reaction solvent, temperature, and con-
centration, as well as a catalyst screen. The synthetic utility
of this enal intermediate has been further demonstrated
through the total synthesis of D12-prostaglandin J3, a com-
pound with known anti-leukemic properties.
Interest in the chemistry and biology of prostanoids continues
unabated, with as many publications (ca. 600 per year) in the
last decade as during their heyday of the 1970s.[1] Prostaglan-
dins are an important class of potent lipid mediators that are
involved in the regulation of many biological processes[2] such
as inflammation,[3] pain response,[4] and fever.[5] Consequently,
this class of compounds has found wide-spread use as phar-
maceuticals[6] for the treatment of several diseases including
pulmonary arterial hypertension[7] and glaucoma.[8] We recently
described a dramatically short route to the prostaglandins,
completing the total synthesis of PGF2a in just seven steps
(Scheme 1),[9] and its subsequent application to the concise
synthesis of the related pharmaceutical analogues latanaprost
and bimatoprost,[10] and alfaprostol.[11] The key step in our syn-
thesis is the double aldol dimerization of succinaldehyde with
proline and dibenzylammonium trifluoroacetate (DBA) as cata-
lysts to give the bicyclic enal intermediate (1) in high enantio-
selectivity (Scheme 1).[12] Whilst this single step converts a
simple starting material into a complex intermediate[13] fully
primed to enable rapid attachment of the two side chains re-
quired, its Achilles’ heel is its low yield (caused by the exten-
sive oligomerization of succinaldehyde under the reaction con-
ditions).
In this paper, we describe a full re-investigation of this key
step, which has culminated in an increase in yield from 14%[9a]
to a 29% isolated yield on a multi-gram scale, thereby ena-
bling the enal 1 to be used not just in further, more efficient
prostanoid syntheses, but also as a highly functionalized and
useful building block more generally. Furthermore, we demon-
strate its application to the concise synthesis of D12-PGJ3, a
prostanoid of considerable contemporary interest due to its
high activity against cancer stem cells, a class of cells that are
notoriously resistant toward conventional chemical thera-
pies.[14]
The aldol dimerization of succinaldehyde is complex: l-pro-
line (2%) is added to a 2m solution of succinaldehyde in Me-
THF and after 24 h the mixture is diluted to 1m and dibenzy-
lammonium trifluoroacetate (5, 2%) is added. The two catalysts
perform different roles: l-proline catalyzes the first aldol but
does not catalyze the second aldol and 5 catalyzes the second
aldol condensation and does not (and must not) catalyze the
first aldol otherwise the reaction would occur with low enan-
Scheme 1. Previously reported l-proline catalyzed double aldol domino re-
action for the synthesis of a key bicyclic enal intermediate 1 and its applica-
tion to the total synthesis of PGF2a (2).
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tioselectivity. The catalysts must be added sequentially be-
cause 5 inhibits the first aldol reaction with proline and the
time of addition is important since reaction of succinaldehyde
with l-proline leads to oligomers over time. Under these condi-
tions, a 14% yield was achieved (Table 1, entry 1), and so we
embarked on a further optimization program re-investigating
all the parameters. A small improvement in yield (16%) was
achieved by changing the solvent to acetonitrile (Table 1,
entry 2). The yield was further increased to 19% (NMR) by re-
ducing the initial concentration to 1m (entry 3), but under
these reaction conditions, the enal was isolated in only 9%
yield. This disparity between the NMR and isolated yields was
a consequence of the formation of a hemiaminal ether by-
product 4, which formed upon addition of catalyst 5 to the
lactol moiety of 1 during the isolation process. An extensive
screening of the second catalyst was undertaken, and we
found that the formation of the hemiaminal ether by-product
could be avoided using thiomorpholinium trifluoroacetate 6,
resulting in 20% yield (both NMR and isolated) of the enal 1
(entry 4). Increasing the temperature of the second step led to
an improved 23% yield in just 2 h (entry 5). An extensive sol-
vent study (see the Supporting Information for further exam-
ples) revealed that whilst ethyl acetate performed similarly to
acetonitrile (21% vs. 23%, entries 5 and 6, respectively), it led
to significantly less oligomerization of succinaldehyde. Reduc-
ing the concentration further in both the first and second
phases of the reaction resulted in further improvements (en-
tries 7 and 8) culminating in a 33% NMR yield and 31% isolat-
ed yield (entry 8). On scale, isolation was initially problematic.
Evaporation followed by chromatography was ineffective,
giving enal 1 contaminated by both oligomers and succinalde-
hyde. We were wary of carrying out an aqueous work-up be-
cause we had previously found that the enal is partially water
soluble and required multiple extractions even from brine solu-
tions, resulting in excessively large volumes of solvent. Howev-
er, a recent report highlighting the beneficial effects of using
Na2SO4 to salt-out water soluble compounds prompted us to
reinvestigate aqueous work-ups.[15] Using this strategy, just two
extractions enabled full recovery of enal 1, which was purified
by column chromatography; it was essential to pre-treat the
silica gel with water (50 wt%) to ensure efficient removal of
any remaining succinaldehyde and oligomeric material during
chromatography. Using our optimized conditions and im-
proved work-up and purification, 50 g of succinaldehyde was
transformed into 12.8 g of enal 1 (29% isolated yield) as an in-
consequential 4:1 mixture of diastereomers, and with the same
enantiomeric ratio (99:1 er) as previously reported.
In order to further exemplify the synthetic utility of the
enal 1, we chose D12-prostaglandin J3 (D
12-PGJ3, 3, Scheme 1)
as a target because of its considerable biological potency to-
wards stem cell cancer.[14] Nicolaou and co-workers recently re-
ported several strategies for the total syntheses of D12-PGJ3.
[16]
These strategies were subsequently applied to the develop-
ment of a series of even more potent analogues as potential
clinical candidates for stem cell cancer treatment, making this
an even more sought-after target.[17] We have previously used
1 to form the C12@C13 bond (prostaglandin numbering) in the
syntheses of a variety of prostanoids through conjugate addi-
tion of a nucleophile to the electrophilic enal moiety
(Scheme 2A). We reasoned that, by transforming enal 1 into
enamide 7, it would change the reactivity of the C12-position
from electrophilic to nucleophilic, further broadening the utili-
ty of our key enal (Scheme 2A). In order to construct D12-PGJ3,
disconnection of the C12@C13 bond through an aldol/dehydra-
Table 1. Re-optimization of the synthesis of enal 1.[a]
Entry Solvent 2nd Cat. T [8C] t [h] Conc. 1 [m] Conc. 2 [m] Yield [%][b]
1 THF 5 RT 14 2.0 1.0 14
2 MeCN 5 RT 20 2.0 1.0 16
3 MeCN 5[c] RT 24 1.0 1.0 19 (9)
4 MeCN 6[c] RT 24 1.0 1.0 20 (20)
5 MeCN 6 65 2 2.0 2.0 23
6 EtOAc 6 65 2 2.0 2.0 21
7 EtOAc 6 65 2 1.0 0.5 28
8[d] EtOAc 6 65 2 0.75 0.2 33 (31)
9[d,e] EtOAc 6 65 2 0.75 0.35 32 (29)
[a] Reaction conditions (unless otherwise stated): Succinaldehyde
(5.81 mmol), l-proline (2 mol%), solvent (X m), RT; then: 2nd catalyst
(2 mol%). [b] Yield determined by 1H NMR spectroscopy using 1,3,5-trime-
thoxybenzene as an internal standard (isolated yields following chromato-
graphic purification are shown in parentheses). [c] 5 mol% of the 2nd cat-
alyst was used. [d] 40 h reaction time for 1st step. [e] 50 g succinaldehyde
(581 mmol) was used.
Scheme 2. A) Changing reactivity mode of our bicyclic enal intermediate
from electrophilic to nucleophilic. B) Retrosynthetic analysis of D12-PGJ3 3.
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tion reaction sequence would require b-boryl aldehyde 8 and
enone 9 (Scheme 2B). This type of aldol/dehydration strategy
was originally reported by Kobayashi[18] and has subsequently
been applied to the syntheses of D12-PGJ3 3
[16a,b,17] and other
closely related prostaglandins.[19] Boryl aldehyde 8 was selected
as a masked hydroxy aldehyde equivalent because it can be
easily prepared by catalytic enantioselective conjugate boryla-
tion,[20] and subsequently unmasked later in the synthesis by
stereospecific oxidation of the boronic ester.
Furthermore, it avoids potential elimination of a protected
d-alkoxy enone to the dieneone. Enone 9 could be obtained
by olefination of hemiacetal 11, followed by hydrolysis of the
carbamate group and elimination. The carbamate itself could
be derived from carboxylic acid 13.
The synthesis of D12-PGJ3 3 began through a double oxida-
tion of enal 1 to the lactone-acid 13 using standard Pinnick ox-
idation conditions in 74% yield (Scheme 3). Carboxylic acid 13
was initially converted into acyl azide 14 in 80% yield. Heating
14 in toluene effected a Curtius rearrangement to afford an in-
termediate isocyanate, which was trapped with benzyl alcohol
to give carbamate 12 in 90% yield. While it was possible to
obtain 12 directly by adding benzyl alcohol to the cooled tolu-
ene solution, this led to sluggish nucleophilic capture reac-
tions. It was crucial to remove toluene before alcohol addition
to ensure a high yield of 12. Ene-carbamate 12 was then re-
duced to hemiacetal 11 with DIBAL-H in 98% yield. Initially, the
Wittig reaction between hemiacetal 11 and phosphonium
salt 10 was problematic due to poor conversion of 11 and the
enamide product 15 was found to be difficult to isolate per-
haps due to its limited stability. After considerable optimiza-
tion, it was found that isolation of the enamide 15 could be
avoided by first treating the hemiacetal 11 with excess phos-
phonium salt 10 and KOt-Amyl in THF. Direct addition of de-
gassed water and para-toluenesulfonic acid to the reaction
mixture effected the hydrolysis of the enamide group and de-
hydration to give enone 16 in 79% yield. The enone acid 16
was subsequently converted into the tert-butyl ester 9 in 83%
yield.
The lower side chain was prepared in a three-step process
from leaf alcohol 19 (Scheme 3). Following a known literature
procedure,[21] 19 was converted into a,b-unsaturated ester 20
by initial oxidation to the corresponding alcohol, followed by a
direct Wittig reaction in the same pot. Ester 20 was subjected
to catalytic asymmetric conjugate addition with B2pin2,
[20a] to
provide a b-boryl ester in high yield and enantiomeric ratio
(85%, 93:7 e.r.). The boronic ester was subsequently reduced
Scheme 3. Synthetic route to D12-PGJ3 (3) from enal 1 and leaf alcohol (19).
Chem. Eur. J. 2018, 24, 9542 – 9545 www.chemeurj.org T 2018 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim9544
Communication
to the required b-boryl aldehyde 8 in 93% yield upon treat-
ment with DIBAL-H.
To complete the synthesis of D12-PGJ3 (3), we commenced
the development of an aldol reaction between enantiomeri-
cally enriched fragments 8 and 9 (Scheme 3). Initially, 1.2 equiv-
alents of LDA were added dropwise to a solution of 8 and 9 at
@78 8C to give the expected aldol product 17 as a mixture of
C13-epimers in 23% NMR yield (Scheme 3). Increasing the
loading of LDA to 2.0 equivalents dramatically improved the
reaction to provide 17 in a 75% NMR yield. Due to the instabil-
ity of b-hydroxy boronic ester 17 towards column chromatog-
raphy, the crude reaction mixture from the aldol reaction was
treated with MsCl and NEt3 to give the corresponding mesy-
late, and subsequent elimination upon reaction with DBU pro-
duced exclusively the E-configured elimination product. The re-
sulting boronic ester was oxidized to secondary alcohol 18
using NaBO3·4H2O in 23% overall yield (over the three steps
from 8 and 9). Finally, treatment with HBF4 gave D
12-PGJ3 (3) in
a 75% yield. The total synthesis of D12-PGJ3 (3) was achieved in
12 steps (longest linear sequence, LLS).
In conclusion, we have significantly improved the yield of
our previously reported l-proline catalyzed double aldol dime-
rization of succinaldehyde from 14 to 29% for the synthesis of
a key enal intermediate 1 that can be employed in the synthe-
sis of a range of prostanoids. This has been achieved through
a thorough re-evaluation of all of the reaction parameters,
which led us to make four key modifications of the reaction
conditions: changing Me-THF for EtOAc, changing dibenzylam-
monium trifluoroacetate 5 to thiomorpholinium trifluoroace-
tate 6, the temperature of the second step from 25 8C to 65 8C,
and the concentration has been decreased from 2m to 0.75m
in the first step and from 1m to 0.35m in the second step. The
synthesis, and the practical isolation and purification of enal 1
on a decagram scale has also been developed. Furthermore,
we have exemplified the synthetic versatility our enal inter-
mediate 1 through its application to the total synthesis of D12-
PGJ3 (3). This was achieved through an umpolung approach in-
volving the conversion of the electrophilic enal moiety into an
ene-carbamate, which serves as a masked nucleophilic moiety.
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